Clinical trials
Active, not recruiting Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ANRS, Emerging Infectious Diseases | 2 |
| Amit D Tevar, MD | 1 |
| April M Young | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Center of target therapy | 1 |
| Mayo Clinic | 1 |
| Memorial University of Newfoundland | 1 |
| Montefiore Medical Center | 1 |
| National Cancer Institute (NCI) | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 20 |
| Carcinoma, Hepatocellular | 3 |
| HIV Infections | 3 |
| Substance-Related Disorders | 3 |
| Hepatitis C, Chronic | 2 |
| Opioid-Related Disorders | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
| Drug Overdose | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.